Table 2

Risk of exposure according to drug formulation

Drug formulationPotential risk of chronic ­toxicity through skin contactPotential risk of acute ­toxicity through skin contactPotential risk of chronic ­toxicity through inhalationPotential risk of acute ­toxicity through inhalationPotential risk of acute ­toxicity through eyes contact
Oral administration
 Uncoated tabletsYesYesNo (except crushed)No (except crushed)No (except crushed)
 Coated tabletsNo (except crushed)No (except crushed)No (except crushed)No (except crushed)No (except crushed)
 CapsulesNo (except opened)No (except opened)No (except opened)No (except opened)No (except opened)
 Powder for oral solutionYesYesYesNoNo
 Oral solutionYesYesNoNoNo
Parenteral administration
 Powder for intravenous solutionYesYesYesNoNo
 Intravenous solutionYesYesNoNoNo
Local administration
 Cream, gelYesYesNoNoNo
 Topic solutionYesYesYesYesYes
 SprayYesYesNoNoNo
 Solution for inhalationYesYesYesYesYes